Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cytoskeletal protein binding	ROCK2 KIF21B TRPM7 STRBP SYNE1 APC2 MTSS1 MIB2 ACTN1 PPARG PTK2 TULP1 MYO3A SETD2 MYOZ1 XIRP2 TTLL4 MYO1F RITA1 RAB11FIP5 MICAL3 MYO15A SNTB2	1.09e-05	1099	153	23	GO:0008092
GeneOntologyMolecularFunction	actin binding	TRPM7 SYNE1 MTSS1 MIB2 ACTN1 PTK2 TULP1 MYO3A MYOZ1 XIRP2 MYO1F MICAL3 MYO15A SNTB2	1.98e-05	479	153	14	GO:0003779
GeneOntologyMolecularFunction	nuclear receptor activity	ESR1 NR6A1 PPARD PPARG NR1H4	9.62e-05	60	153	5	GO:0004879
GeneOntologyMolecularFunction	ligand-activated transcription factor activity	ESR1 NR6A1 PPARD PPARG NR1H4	1.04e-04	61	153	5	GO:0098531
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	ROCK2 NAGK TRPM7 POLR2A PARP2 TUT7 GLYCTK SCYL1 PFKFB3 PAPSS1 YES1 PTK2 IDNK MYO3A BRD4 DCLK3 DGKI ALK ALPK2	1.05e-04	938	153	19	GO:0016772
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	ROCK2 NAGK TRPM7 GLYCTK SCYL1 PFKFB3 PAPSS1 YES1 PTK2 IDNK MYO3A BRD4 DCLK3 DGKI ALK ALPK2	1.12e-04	709	153	16	GO:0016773
GeneOntologyMolecularFunction	kinase activity	ROCK2 NAGK TRPM7 GLYCTK SCYL1 PFKFB3 PAPSS1 YES1 PTK2 IDNK MYO3A BRD4 DCLK3 DGKI ALK ALPK2	2.62e-04	764	153	16	GO:0016301
GeneOntologyMolecularFunction	actin filament binding	SYNE1 MTSS1 ACTN1 TULP1 MYO3A XIRP2 MYO1F MYO15A	3.72e-04	227	153	8	GO:0051015
GeneOntologyMolecularFunction	RNA cap binding	DCPS EIF4E1B EIF4G3	5.30e-04	21	153	3	GO:0000339
GeneOntologyMolecularFunction	transcription coregulator binding	FOXO3 ESR1 PPARD PPARG ZNF644 NR1H4	7.41e-04	140	153	6	GO:0001221
GeneOntologyBiologicalProcess	miRNA metabolic process	FOXO3 ESR1 TUT7 PPARD PPARG ZNF512B NOTCH3	2.43e-05	119	148	7	GO:0010586
GeneOntologyBiologicalProcess	regulation of miRNA transcription	FOXO3 ESR1 PPARD PPARG ZNF512B NOTCH3	2.95e-05	83	148	6	GO:1902893
GeneOntologyBiologicalProcess	miRNA transcription	FOXO3 ESR1 PPARD PPARG ZNF512B NOTCH3	3.16e-05	84	148	6	GO:0061614
GeneOntologyBiologicalProcess	negative regulation of miRNA transcription	ESR1 PPARD PPARG ZNF512B	6.89e-05	31	148	4	GO:1902894
GeneOntologyBiologicalProcess	negative regulation of cellular response to oxidative stress	OXR1 SCLY MEAK7	7.60e-05	12	148	3	GO:1900408
GeneOntologyBiologicalProcess	regulation of miRNA metabolic process	FOXO3 ESR1 PPARD PPARG ZNF512B NOTCH3	9.95e-05	103	148	6	GO:2000628
GeneOntologyBiologicalProcess	negative regulation of miRNA metabolic process	ESR1 PPARD PPARG ZNF512B	9.98e-05	34	148	4	GO:2000629
GeneOntologyBiologicalProcess	positive regulation of adipose tissue development	PPARG SH3PXD2B NR1H4	1.24e-04	14	148	3	GO:1904179
Domain	Znf_hrmn_rcpt	ESR1 NR6A1 PPARD PPARG NR1H4	3.73e-05	46	154	5	IPR001628
Domain	NUCLEAR_REC_DBD_2	ESR1 NR6A1 PPARD PPARG NR1H4	3.73e-05	46	154	5	PS51030
Domain	NUCLEAR_REC_DBD_1	ESR1 NR6A1 PPARD PPARG NR1H4	3.73e-05	46	154	5	PS00031
Domain	ZnF_C4	ESR1 NR6A1 PPARD PPARG NR1H4	3.73e-05	46	154	5	SM00399
Domain	zf-C4	ESR1 NR6A1 PPARD PPARG NR1H4	3.73e-05	46	154	5	PF00105
Domain	Nuclear_hrmn_rcpt	ESR1 NR6A1 PPARD PPARG NR1H4	3.73e-05	46	154	5	IPR001723
Domain	-	ESR1 NR6A1 PPARD PPARG NR1H4	4.14e-05	47	154	5	1.10.565.10
Domain	Nucl_hrmn_rcpt_lig-bd	ESR1 NR6A1 PPARD PPARG NR1H4	4.59e-05	48	154	5	IPR000536
Domain	HOLI	ESR1 NR6A1 PPARD PPARG NR1H4	4.59e-05	48	154	5	SM00430
Domain	Hormone_recep	ESR1 NR6A1 PPARD PPARG NR1H4	4.59e-05	48	154	5	PF00104
Domain	-	ESR1 NR6A1 PPARD PPARG NR1H4	1.06e-04	57	154	5	3.30.50.10
Domain	Znf_NHR/GATA	ESR1 NR6A1 PPARD PPARG NR1H4	1.15e-04	58	154	5	IPR013088
Domain	1Cnucl_rcpt	PPARD PPARG	2.02e-04	3	154	2	IPR003074
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	RBM15 ERCC3 SPTLC2 POLR2A TUT7 RSF1 PSMC4 ACTN1 PTK2 NCCRP1 DNAJA3 CCNT1 SMG8 FASN GTF3C1 PES1 RCL1 UTP20 PLEKHA5 PRR14L TAF2 HSPA9 AHNAK2	3.76e-08	1353	155	23	29467282
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	TRPM7 ACOT9 SYNE1 TUT7 SELENOH SCYL1 PSMC4 TACC2 ARMCX2 USP19 ZNF512B KIAA1671 DNAJA3 NDUFAF7 ZNF644 RCL1 MLF1 NAV1 MINDY4 HSPA9 MIEF2 PRRC2B AHNAK2 SMG6	5.44e-08	1496	155	24	32877691
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	ROCK2 STRBP SYNE1 PPFIA2 CHAF1A RSF1 BAG1 RBM42 ANKRD30B PABPC5 ACTN1 ALG2 FASN TNRC18 GTF3C1 TCHHL1 PES1 LSM14A EIF4G3 RPL3L HSPA9 PRRC2B SLC17A6	1.18e-07	1442	155	23	35575683
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	DPH7 CHAF1A POLR2A TUT7 PSMC4 NCKAP5L ZCCHC14 SETD2 TTLL4 WBP4 PES1 NUFIP2 MLF1 NAV1 PLEKHA5 PRR14L	2.03e-07	733	155	16	34672954
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	ERCC3 SYNE1 ESR1 CHAF1A POLR2A PARP2 RBM42 ACTN1 YES1 KIAA1671 TMX2 CCNT1 SETD2 PES1 RCL1 NUFIP2 UTP20 LSM14A TAF2 EIF4G3 USP6NL SNTB2 SMG6	2.29e-07	1497	155	23	31527615
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	RBM15 STRBP POLR2A TUT7 RSF1 ACTN1 FASN GTF3C1 PES1 RCL1 NUFIP2 UTP20 EIF4G3 HSPA9 PRRC2B	2.62e-07	653	155	15	22586326
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	FOXO3 IFFO1 ACOT9 TUT7 CNTLN GTPBP1 NCKAP5L YES1 KIAA1671 DNAJA3 SH3PXD2B MLF1 MICAL3 MINDY4 TAF2 HSPA9 PRRC2B	2.97e-07	853	155	17	28718761
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	FOXO3 RBM15 HIVEP2 TRPM7 GIGYF1 NCKAP5L KIAA1671 ZCCHC14 FAM171A1 SH3PXD2B BRD4 NAV1 RAB11FIP5 PLEKHA5 EIF4G3 USP6NL AHNAK2	3.38e-07	861	155	17	36931259
Pubmed	Enhanced J-protein interaction and compromised protein stability of mtHsp70 variants lead to mitochondrial dysfunction in Parkinson's disease.	DNAJC19 DNAJA3 HSPA9	3.46e-07	4	155	3	22544056
Pubmed	The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis.	PPFIA2 GIGYF1 NCKAP5L ZCCHC14 SH3PXD2B TAX1BP1 MYO1F PRRC2B SMG6	6.45e-07	218	155	9	33378226
Pubmed	An adipogenic cofactor bound by the differentiation domain of PPARgamma.	ESR1 PPARD PPARG	8.63e-07	5	155	3	10393183
Pubmed	Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARbeta activity.	ESR1 PPARD PPARG	8.63e-07	5	155	3	12962497
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	RBM15 ERCC3 ACOT9 PARP2 TUT7 ACTN1 GTPBP1 KIAA1671 DNAJA3 FASN GTF3C1 PES1 RCL1 NUFIP2 NAV1 UTP20 PLEKHA5 LSM14A HSPA9 SNTB2	8.88e-07	1257	155	20	36526897
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	POLR2A RSF1 TACC2 PSME2 ZNF512B KIAA1671 CCNT1 SETD2 FASN PES1 NUFIP2 LSM14A PRR14L EIF4G3 HSPA9 PRRC2B AHNAK2	1.04e-06	934	155	17	33916271
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	FOXO3 ASXL1 STRBP CHAF1A POLR2A PARP2 RELB PPARG FASN GTF3C1 AGL ZNF644 PES1 RITA1 UTP20 NOTCH3	1.58e-06	857	155	16	25609649
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	RBM15 DCPS BAG1 PSMC4 ACTN1 PSME2 PPARG GTPBP1 CCNT1 FASN TNRC18 GTF3C1 ZNF644 BRD4 PES1 LSM14A HSPA9 PRRC2B	2.29e-06	1103	155	18	34189442
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	FOXO3 HIVEP2 POLR2A UBE3B RELB MIB2 ZCCHC14 SH3PXD2B FASN TNRC18 BRD4 TTLL4 NAV1 MICAL3 PRDM16 PRRC2B AHNAK2 SMG6	2.35e-06	1105	155	18	35748872
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ASXL1 SYNE1 VAT1L ZNF365 USP19 ZCCHC14 ZNF644 NUFIP2 NAV1 MICAL3 PRRC2B	2.36e-06	407	155	11	12693553
Pubmed	Automated yeast two-hybrid screening for nuclear receptor-interacting proteins.	FOXO3 ESR1 PSMC4 ACTN1 PPARD PPARG NR1H4	2.37e-06	133	155	7	15604093
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	ROCK2 RBM15 CHAF1A RSF1 TACC2 GIGYF1 FASN GTF3C1 NUFIP2 PLEKHA5 EIF4G3 SNTB2	2.94e-06	503	155	12	16964243
Pubmed	RNA polymerase II-associated factor 1 regulates the release and phosphorylation of paused RNA polymerase II.	POLR2A CCNT1 BRD4	3.00e-06	7	155	3	26659056
Pubmed	High frequency of a retinoid X receptor gamma gene variant in familial combined hyperlipidemia that associates with atherogenic dyslipidemia.	PPARD PPARG NR1H4	3.00e-06	7	155	3	17272748
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	ROCK2 RBM15 STRBP SYNE1 POLR2A TUT7 SELENOH FASN PES1 NUFIP2 UTP20 LSM14A EIF4G3 HSPA9 PRRC2B	3.60e-06	807	155	15	22681889
Pubmed	TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions.	ASXL1 RBM15 POLR2A PARP2 PSMC4 RELB PABPC5 PPARG PAPSS1 NCKAP5L ZNF512B ZCCHC14 FAM171A1 FASN RAB11FIP5 PLEKHA5	4.02e-06	922	155	16	27609421
Pubmed	Role of Magmas in protein transport and human mitochondria biogenesis.	DNAJC19 DNAJA3 HSPA9	4.78e-06	8	155	3	20053669
Pubmed	Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	SYNE1 TUT7 SETD2 DCLK3 PLEKHA5 PRDM16	6.73e-06	102	155	6	11214970
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	POLR2A ACTN1 KIAA1671 SETD2 SH3PXD2B FASN GTF3C1 BRD4 NUFIP2 PLEKHA5 TAF2 PRRC2B	7.14e-06	549	155	12	38280479
Pubmed	Gadd45 family proteins are coactivators of nuclear hormone receptors.	ESR1 PPARD PPARG	7.15e-06	9	155	3	10872826
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	ROCK2 FOXO3 IFFO1 UBE3B SCYL1 PSMC4 GIGYF1 ACTN1 NCKAP5L TULP1 KIAA1671 POSTN NUFIP2 TTC21B MLF1 NAV1 PLEKHA5 MINDY4 PRRC2B	7.27e-06	1321	155	19	27173435
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	ACOT9 STRBP TUT7 UBE3B MIB2 GIGYF1 GTPBP1 PTK2 SMG8 GTF3C1 PLEKHA5 MICAL3 PRRC2B	7.62e-06	650	155	13	38777146
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	TRPM7 DNAJC19 SYNE1 BAG1 PSMC4 DNAJC27 NCKAP5L YES1 ZNF512B DNAJA3 FAM171A1 ZNF644 PES1 RCL1 RAB11FIP5 PLEKHA5 EIF4G3 USP6NL HSPA9 SNTB2	1.10e-05	1487	155	20	33957083
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	RBM15 ERCC3 STRBP TUT7 SELENOH RBM42 PSMC4 GTPBP1 FASN TCHHL1 AGL TAX1BP1 PES1 RCL1 NUFIP2 LSM14A ALK HSPA9 PRRC2B	1.22e-05	1371	155	19	36244648
Pubmed	Interaction of nuclear receptor zinc finger DNA binding domains with histone deacetylase.	IKZF2 PPARD PPARG	1.40e-05	11	155	3	12943985
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	NBEAL1 CHAF1A PARP2 RSF1 PSMC4 GIGYF1 MEAK7 NCCRP1 TNRC18 SKOR2 DGKI TAF2 PRRC2B	1.41e-05	689	155	13	36543142
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	SOX1 FOXO3 IKZF2 ESR1 TUT7 NR6A1 PPARD PKHD1L1 ZCCHC14 ZNF644 BRD4 WBP4 PRDM16 UTF1	1.69e-05	808	155	14	20412781
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	ASXL1 DONSON SH3PXD2B FASN TNRC18 NAV1 ALPK2 PRRC2B AHNAK2	1.96e-05	332	155	9	37433992
Pubmed	Mechanisms of vascular dysfunction in mice with endothelium-specific deletion of the PPAR-δ gene.	PPARD PPARG	1.97e-05	2	155	2	24486511
Pubmed	The function of the nuclear receptor peroxisome proliferator-activated receptor delta in energy homeostasis.	PPARD PPARG	1.97e-05	2	155	2	14677574
Pubmed	Pleiotropic effects of peroxisome proliferator-activated receptor γ and δ in vascular diseases.	PPARD PPARG	1.97e-05	2	155	2	24107399
Pubmed	The Impact of PPARD and PPARG Polymorphisms on Glioma Risk and Prognosis.	PPARD PPARG	1.97e-05	2	155	2	32198386
Pubmed	Association of peroxisome proliferator-activated receptor α/δ/γ with obesity, and gene-gene interaction, in the Chinese Han population.	PPARD PPARG	1.97e-05	2	155	2	23545576
Pubmed	Estrogen receptor-{alpha} promotes endothelial cell motility through focal adhesion kinase.	ESR1 PTK2	1.97e-05	2	155	2	21127007
Pubmed	Farnesoid X receptor regulates forkhead Box O3a activation in ethanol-induced autophagy and hepatotoxicity.	FOXO3 NR1H4	1.97e-05	2	155	2	25460735
Pubmed	Influence of tumor peroxisome proliferator-activated receptor gamma and delta expression on postoperative mortality of patients undergoing colorectal cancer surgery.	PPARD PPARG	1.97e-05	2	155	2	19283612
Pubmed	Cinnamaldehyde Contributes to Insulin Sensitivity by Activating PPARδ, PPARγ, and RXR.	PPARD PPARG	1.97e-05	2	155	2	26227398
Pubmed	Transcriptional profiling and regulation of the extracellular matrix during muscle regeneration.	BGN POSTN	1.97e-05	2	155	2	12799472
Pubmed	Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells.	YES1 PTK2	1.97e-05	2	155	2	25868388
Pubmed	Estrogen receptor-associated receptor α and peroxisome proliferator-activated receptor γ in metabolism and disease (Review).	ESR1 PPARG	1.97e-05	2	155	2	33355368
Pubmed	ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study.	SYNE1 ESR1	1.97e-05	2	155	2	20056644
Pubmed	A protein that interacts with members of the nuclear hormone receptor family: identification and cDNA cloning.	ESR1 BAG1	1.97e-05	2	155	2	8524784
Pubmed	Germ cell nuclear factor directly represses the transcription of peroxisome proliferator-activated receptor delta gene.	NR6A1 PPARD	1.97e-05	2	155	2	18330480
Pubmed	Disruption of ERalpha signalling pathway by PPARgamma agonists: evidences of PPARgamma-independent events in two hormone-dependent breast cancer cell lines.	ESR1 PPARG	1.97e-05	2	155	2	18204896
Pubmed	Female-specific regulation of skeletal muscle mass by USP19 in young mice.	ESR1 USP19	1.97e-05	2	155	2	25901042
Pubmed	Peroxisome proliferator-activated receptor-γ and -δ polymorphisms in women with polycystic ovary syndrome.	PPARD PPARG	1.97e-05	2	155	2	20840271
Pubmed	Tid1-S attenuates LPS-induced cardiac hypertrophy and apoptosis through ER-a mediated modulation of p-PI3K/p-Akt signaling cascade.	ESR1 DNAJA3	1.97e-05	2	155	2	31081962
Pubmed	Comparison of PPARδ and PPARγ in inhibiting the pro-inflammatory effects of C-reactive protein in endothelial cells.	PPARD PPARG	1.97e-05	2	155	2	19395102
Pubmed	Raised hepatic bile acid concentrations during pregnancy in mice are associated with reduced farnesoid X receptor function.	ESR1 NR1H4	1.97e-05	2	155	2	20842631
Pubmed	Estrogen and Estrogen Receptor-α-Mediated Transrepression of Bile Salt Export Pump.	ESR1 NR1H4	1.97e-05	2	155	2	25675114
Pubmed	Identification of a novel FAS/ER-alpha fusion transcript expressed in human cancer cells.	ESR1 FASN	1.97e-05	2	155	2	11018265
Pubmed	The effects of kefir, koumiss, yogurt and commercial probiotic formulations on PPARα and PPAR-β/δ expressions in mouse kidney.	PPARD PPARG	1.97e-05	2	155	2	24205877
Pubmed	Modulation of the Brd4/P-TEFb interaction by the human T-lymphotropic virus type 1 tax protein.	CCNT1 BRD4	1.97e-05	2	155	2	17686863
Pubmed	Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma.	PPARD PPARG	1.97e-05	2	155	2	23374874
Pubmed	PPARγ agonists induce a white-to-brown fat conversion through stabilization of PRDM16 protein.	PPARG PRDM16	1.97e-05	2	155	2	22405074
Pubmed	Peroxisome proliferator-activated receptor-β/δ, the acute signaling factor in prostacyclin-induced pulmonary vasodilation.	PPARD PPARG	1.97e-05	2	155	2	22021335
Pubmed	NPM-ALK fusion kinase of anaplastic large-cell lymphoma regulates survival and proliferative signaling through modulation of FOXO3a.	FOXO3 ALK	1.97e-05	2	155	2	14962911
Pubmed	Haematopoietic focal adhesion kinase deficiency alters haematopoietic homeostasis to drive tumour metastasis.	POLR2A PTK2	1.97e-05	2	155	2	25270220
Pubmed	Deregulation of tumor angiogenesis and blockade of tumor growth in PPARbeta-deficient mice.	PPARD PPARG	1.97e-05	2	155	2	17641685
Pubmed	ALK upregulates POSTN and WNT signaling to drive neuroblastoma.	POSTN ALK	1.97e-05	2	155	2	38451815
Pubmed	TID1, a human homolog of the Drosophila tumor suppressor l(2)tid, encodes two mitochondrial modulators of apoptosis with opposing functions.	DNAJA3 HSPA9	1.97e-05	2	155	2	10411904
Pubmed	Activation of PPARγ and δ by dietary punicic acid ameliorates intestinal inflammation in mice.	PPARD PPARG	1.97e-05	2	155	2	21736821
Pubmed	The effect of neuronal conditional knock-out of peroxisome proliferator-activated receptors in the MPTP mouse model of Parkinson's disease.	PPARD PPARG	1.97e-05	2	155	2	26028469
Pubmed	Solution structure of the Set2-Rpb1 interacting domain of human Set2 and its interaction with the hyperphosphorylated C-terminal domain of Rpb1.	POLR2A SETD2	1.97e-05	2	155	2	16314571
Pubmed	The estrogen receptor α is the key regulator of the bifunctional role of FoxO3a transcription factor in breast cancer motility and invasiveness.	FOXO3 ESR1	1.97e-05	2	155	2	24047697
Pubmed	ALK fusion promotes metabolic reprogramming of cancer cells by transcriptionally upregulating PFKFB3.	PFKFB3 ALK	1.97e-05	2	155	2	36064579
Pubmed	Growth and early postimplantation defects in mice deficient for the bromodomain-containing protein Brd4.	BRD4 NOTCH3	1.97e-05	2	155	2	11997514
Pubmed	Circ-DONSON promotes malignant progression of glioma through modulating FOXO3.	FOXO3 DONSON	1.97e-05	2	155	2	32016978
Pubmed	Peroxisome-proliferator-activated receptors γ and β/δ mediate vascular endothelial growth factor production in colorectal tumor cells.	PPARD PPARG	1.97e-05	2	155	2	20221637
Pubmed	PFKFB3 regulates breast cancer tumorigenesis and Fulvestrant sensitivity by affecting ERα stability.	ESR1 PFKFB3	1.97e-05	2	155	2	38640982
Pubmed	17β-estradiol represses myogenic differentiation by increasing ubiquitin-specific peptidase 19 through estrogen receptor α.	ESR1 USP19	1.97e-05	2	155	2	21971047
Pubmed	The function of peroxisome proliferator-activated receptors PPAR-γ and PPAR-δ in Mycobacterium leprae-induced foam cell formation in host macrophages.	PPARD PPARG	1.97e-05	2	155	2	33075048
Pubmed	+294T/C polymorphism in the PPAR-delta gene is associated with risk of coronary artery disease in normolipidemic Tunisians.	PPARD PPARG	1.97e-05	2	155	2	20645257
Pubmed	PPARδ deficient mice develop elevated Th1/Th17 responses and prolonged experimental autoimmune encephalomyelitis.	PPARD PPARG	1.97e-05	2	155	2	21192919
Pubmed	Endothelial, but not smooth muscle, peroxisome proliferator-activated receptor β/δ regulates vascular permeability and anaphylaxis.	PPARD PPARG	1.97e-05	2	155	2	25556996
Pubmed	Impact of peroxisome proliferator-activated receptors gamma and delta on adiposity in toddlers and preschoolers in the GENESIS Study.	PPARD PPARG	1.97e-05	2	155	2	18379566
Pubmed	PPARβ/δ activation protects against hepatic ischaemia-reperfusion injury.	PPARD PPARG	1.97e-05	2	155	2	37833850
Pubmed	Stoichiometric expression of mtHsp40 and mtHsp70 modulates mitochondrial morphology and cristae structure via Opa1L cleavage.	DNAJA3 HSPA9	1.97e-05	2	155	2	25904328
Pubmed	Haplotype of ESR1 and PPARD Genes Is Associated with Higher Anthropometric Changes in Han Chinese Obesity by Adjusting Dietary Factors-An 18-Month Follow-Up.	ESR1 PPARD	1.97e-05	2	155	2	36297109
Pubmed	Farnesol, a mevalonate pathway intermediate, stimulates MCF-7 breast cancer cell growth through farnesoid-X-receptor-mediated estrogen receptor activation.	ESR1 NR1H4	1.97e-05	2	155	2	17333335
Pubmed	PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages.	PPARD PPARG	1.97e-05	2	155	2	12740443
Pubmed	Foxo3a inhibits mitochondrial fission and protects against doxorubicin-induced cardiotoxicity by suppressing MIEF2.	FOXO3 MIEF2	1.97e-05	2	155	2	28137654
Pubmed	PPARbeta/delta potentiates PPARgamma-stimulated adipocyte differentiation.	PPARD PPARG	1.97e-05	2	155	2	15247146
Pubmed	Activation of PPARδ in bone marrow endothelial progenitor cells improves their hematopoiesis-supporting ability after myelosuppressive injury.	PPARD PPARG	1.97e-05	2	155	2	38704134
Pubmed	Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase.	RSF1 FASN	1.97e-05	2	155	2	20228782
Pubmed	The PAPSS1 gene is a modulator of response to cisplatin by regulating estrogen receptor alpha signaling activity in ovarian cancer cells.	ESR1 PAPSS1	1.97e-05	2	155	2	37684671
Pubmed	The cytoskeletal/non-muscle isoform of alpha-actinin is phosphorylated on its actin-binding domain by the focal adhesion kinase.	ACTN1 PTK2	1.97e-05	2	155	2	11369769
Pubmed	Disruption of inducible 6-phosphofructo-2-kinase impairs the suppressive effect of PPARγ activation on diet-induced intestine inflammatory response.	PFKFB3 PPARG	1.97e-05	2	155	2	22841546
Pubmed	Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells.	POLR2A BRD4	1.97e-05	2	155	2	23086925
Pubmed	Genomic organization of the mouse peroxisome proliferator-activated receptor beta/delta gene: alternative promoter usage and splicing yield transcripts exhibiting differential translational efficiency.	PPARD PPARG	1.97e-05	2	155	2	12059785
Pubmed	Characterization of stem cell-derived liver and intestinal organoids as a model system to study nuclear receptor biology.	PPARG NR1H4	1.97e-05	2	155	2	27956139
Pubmed	Promotion of lipogenesis by PPARγ-activated FXR expression in adipocytes.	PPARG NR1H4	1.97e-05	2	155	2	32446390
Interaction	F9 interactions	ACOT9 MIB2 KIAA1671 SMG8 SETD2 ZNF644	8.39e-07	43	153	6	int:F9
Interaction	YWHAZ interactions	FOXO3 ASXL1 RBM15 HIVEP2 TRPM7 PPFIA2 ESR1 CHAF1A RSF1 TACC2 GIGYF1 PFKFB3 NCKAP5L KIAA1671 FAM171A1 MYO3A ZNF644 BRD4 TAX1BP1 MLF1 NAV1 RAB11FIP5 PLEKHA5 PRR14L EPCAM USP6NL HSPA9	2.12e-06	1319	153	27	int:YWHAZ
Interaction	ARRB1 interactions	FOXO3 ESR1 BAG1 PFKFB3 YES1 FASN BRD4 PES1 RAB11FIP5 PRDM16 HSPA9 ALPK2	3.71e-06	304	153	12	int:ARRB1
Interaction	SIRT7 interactions	RBM15 STRBP ESR1 POLR2A TUT7 RSF1 ACTN1 PSME2 PPARG FASN GTF3C1 BRD4 PES1 RCL1 NUFIP2 UTP20 EIF4G3 HSPA9 PRRC2B	3.81e-06	744	153	19	int:SIRT7
Interaction	CEP135 interactions	DCPS TRPM7 IFFO1 CHAF1A GIGYF1 CNTLN GTPBP1 NCKAP5L KIAA1671 NAV1 PRRC2B	7.60e-06	272	153	11	int:CEP135
Interaction	C1orf35 interactions	NAGK ESR1 NCCRP1 CCNT1 FASN BRD4 PES1 RCL1 NUFIP2 TAF2 INCA1	2.15e-05	304	153	11	int:C1orf35
Interaction	POLR1G interactions	ACOT9 STRBP ESR1 CHAF1A POLR2A RSF1 PSMC4 ZNF512B GTF3C1 ZNF644 BRD4 PES1 UTP20 TAF2	2.25e-05	489	153	14	int:POLR1G
Interaction	YWHAG interactions	FOXO3 KIF21B RBM15 HIVEP2 TRPM7 ESR1 CHAF1A BAG1 GIGYF1 PFKFB3 CNTLN PPARG NCKAP5L PTK2 KIAA1671 FAM171A1 NUFIP2 NAV1 RAB11FIP5 PLEKHA5 EIF4G3 USP6NL HSPA9 AHNAK2	2.37e-05	1248	153	24	int:YWHAG
Interaction	YTHDF2 interactions	ESR1 GIGYF1 GTPBP1 SMG8 FASN AGL NUFIP2 LSM14A EIF4G3 PRRC2B SMG6	2.73e-05	312	153	11	int:YTHDF2
Interaction	FBXO42 interactions	ROCK2 TACC2 CNTLN NCKAP5L KIAA1671 FASN ZNF644 NAV1 RAB11FIP5 PRRC2B	2.96e-05	259	153	10	int:FBXO42
Interaction	WDR82 interactions	NAGK ESR1 POLR2A CCNT1 FASN BRD4 NUFIP2 PLEKHA5 TAF2	3.72e-05	213	153	9	int:WDR82
Interaction	NPM1 interactions	ROCK2 ASXL1 HIVEP2 DNAJC19 ESR1 CHAF1A PARP2 BAG1 RBM42 PSMC4 CCNT1 SETD2 FASN GTF3C1 BRD4 PES1 RCL1 NUFIP2 MINDY4 ALK HSPA9 PRRC2B AHNAK2	3.81e-05	1201	153	23	int:NPM1
Interaction	CTTN interactions	RBM15 ESR1 MTSS1 YES1 PTK2 KIAA1671 CCNT1 BRD4 RCL1 NUFIP2 TAF2 ALK HSPA9	4.06e-05	450	153	13	int:CTTN
Interaction	MEX3B interactions	GIGYF1 GTPBP1 NCKAP5L KIAA1671 ZCCHC14 SMG8 NUFIP2 LSM14A PRRC2B	5.13e-05	222	153	9	int:MEX3B
Interaction	H3C1 interactions	ROCK2 SYNE1 ESR1 CHAF1A POLR2A PARP2 RSF1 ZNF512B SETD2 TNRC18 GTF3C1 XIRP2 ZNF644 BRD4 PES1 PRR14L TAF2 PRDM16 NR1H4	5.45e-05	901	153	19	int:H3C1
Interaction	EIF3H interactions	ESR1 CHAF1A RSF1 RBM42 GIGYF1 MINDY4 TAF2 EIF4G3 HSPA9 PRRC2B	6.07e-05	282	153	10	int:EIF3H
Interaction	FMR1 interactions	ROCK2 KIF21B ESR1 APC2 RBM42 TACC2 FAM171A1 SMG8 BRD4 NUFIP2 LSM14A INCA1 PRRC2B SMG6	6.08e-05	536	153	14	int:FMR1
Interaction	MAPRE3 interactions	ROCK2 TUT7 APC2 TACC2 NCKAP5L KIAA1671 SH3PXD2B NAV1 PLEKHA5	6.75e-05	230	153	9	int:MAPRE3
Interaction	TOP1 interactions	RBM15 DCPS ESR1 POLR2A RSF1 CCNT1 SETD2 GTF3C1 BRD4 TAX1BP1 PES1 RCL1 NUFIP2 UTP20 TAF2 PRDM16	8.15e-05	696	153	16	int:TOP1
Interaction	YWHAH interactions	FOXO3 KIF21B RBM15 HIVEP2 TRPM7 ESR1 BAG1 GIGYF1 PFKFB3 NCKAP5L KIAA1671 ZCCHC14 FAM171A1 SH3PXD2B BRD4 NAV1 RAB11FIP5 PLEKHA5 EIF4G3 USP6NL AHNAK2	9.20e-05	1102	153	21	int:YWHAH
Interaction	EIF3L interactions	ESR1 CHAF1A SCYL1 RBM42 BRD4 TTC21B EIF4G3 PRDM16 PRRC2B	1.06e-04	244	153	9	int:EIF3L
Interaction	MYCN interactions	RBM15 DNAJC19 STRBP SYNE1 TUT7 SELENOH RBM42 PCDHB2 ACTN1 GTPBP1 YES1 ZNF512B DNAJA3 SETD2 GTF3C1 WBP4 PES1 NUFIP2 LSM14A EIF4G3 UTF1 HSPA9 PRRC2B SMG6	1.07e-04	1373	153	24	int:MYCN
Interaction	CCNT2 interactions	CCNT1 FASN BRD4 NUFIP2 TAF2	1.08e-04	62	153	5	int:CCNT2
Interaction	CDC16 interactions	ESR1 CHAF1A SMG8 FASN ZNF644 BRD4 MLF1 PLEKHA5 PRR14L	1.13e-04	246	153	9	int:CDC16
Interaction	DNAJB4 interactions	ESR1 BAG1 GIGYF1 BRD4 TAX1BP1 MLF1 HSPA9	1.22e-04	145	153	7	int:DNAJB4
Interaction	CBX3 interactions	ESR1 CHAF1A POLR2A RSF1 RELB ZNF512B SETD2 FASN GTF3C1 ZNF644 BRD4 TAX1BP1 PRDM16 HSPA9 PRRC2B	1.23e-04	646	153	15	int:CBX3
Interaction	ASF1A interactions	STRBP ESR1 CHAF1A POLR2A ZNF512B CCNT1 FASN GTF3C1 ZNF644	1.24e-04	249	153	9	int:ASF1A
Interaction	CPEB1 interactions	STRBP GIGYF1 GTPBP1 KIAA1671 FASN LSM14A PRRC2B	1.27e-04	146	153	7	int:CPEB1
Interaction	NUSAP1 interactions	ESR1 CHAF1A FASN BRD4 RCL1 TAF2	1.28e-04	102	153	6	int:NUSAP1
Interaction	USP7 interactions	FOXO3 ANKRD31 DNHD1 ANKRD35 RBM15 ERCC3 COL26A1 SYNE1 ESR1 RELB CNTLN PPARG ARMCX2 USP19 DNAJA3 MYO3A BRD4 PES1 MYO1F DGKI MINDY4 PRDM16 HSPA9	1.46e-04	1313	153	23	int:USP7
Interaction	LZTS2 interactions	RBM15 ERCC3 ESR1 GLYCTK GIGYF1 NCKAP5L ZNF512B KIAA1671 MYOZ1 ZNF644 TTLL4 RAB11FIP5 PLEKHA5	1.49e-04	512	153	13	int:LZTS2
Interaction	SART1 interactions	DCPS RBM42 CCNT1 BRD4 WBP4 PES1 RCL1 NUFIP2 TAF2 HSPA9	1.59e-04	317	153	10	int:SART1
Interaction	LSM14A interactions	ROCK2 ESR1 SCYL1 GIGYF1 GTPBP1 SMG8 NUFIP2 LSM14A PRRC2B	1.71e-04	260	153	9	int:LSM14A
Interaction	NSUN2 interactions	ROCK2 ERCC3 DCPS STRBP SCYL1 YES1 FASN BRD4 RCL1 ALK	1.85e-04	323	153	10	int:NSUN2
Interaction	SLTM interactions	DCPS DNAJC19 PABPC5 CCNT1 FASN BRD4 TAX1BP1	1.92e-04	156	153	7	int:SLTM
Interaction	CPSF6 interactions	RBM15 ERCC3 ESR1 POLR2A SELENOH SCYL1 RBM42 YES1 CCNT1 SETD2 BRD4 WBP4 NUFIP2	1.94e-04	526	153	13	int:CPSF6
Interaction	TDRD3 interactions	ESR1 POLR2A GTPBP1 NUFIP2 MLF1 LSM14A PRRC2B SMG6	2.21e-04	212	153	8	int:TDRD3
Interaction	LCK interactions	ESR1 NCKAP5L YES1 PTK2 KIAA1671 FAM171A1 NAV1 PLEKHA5 USP6NL HSPA9 SNTB2 AHNAK2	2.23e-04	463	153	12	int:LCK
Interaction	ZC3H7A interactions	ESR1 MIB2 GIGYF1 SMG8 FASN NUFIP2 LSM14A PRRC2B	2.43e-04	215	153	8	int:ZC3H7A
Interaction	GUSBP5 interactions	KIAA1671 ZCCHC14 SMG8 TNRC18 EIF4G3	2.66e-04	75	153	5	int:GUSBP5
Interaction	PPIL4 interactions	NAGK CCNT1 BRD4 PES1 RCL1 NUFIP2 TAF2	2.70e-04	165	153	7	int:PPIL4
Interaction	MKRN1 interactions	STRBP ESR1 SELENOH PABPC5 PPARG PES1 NUFIP2	2.70e-04	165	153	7	int:MKRN1
Interaction	PMF1 interactions	KIF21B DONSON CHAF1A ZNF644 MLF1 TAF2	2.71e-04	117	153	6	int:PMF1
Interaction	PABPC1 interactions	ROCK2 ESR1 CHAF1A BAG1 RBM42 PABPC5 FASN BRD4 WBP4 NUFIP2 LSM14A EIF4G3 HSPA9 PRRC2B SMG6	2.88e-04	699	153	15	int:PABPC1
Interaction	EIF4E interactions	ROCK2 ASXL1 ESR1 RBM42 EIF4E1B LSM14A EIF4G3 HSPA9	2.92e-04	221	153	8	int:EIF4E
Interaction	TOP3B interactions	FOXO3 RBM15 HIVEP2 POLR2A UBE3B RELB MIB2 ACTN1 GTPBP1 YES1 ZCCHC14 SH3PXD2B FASN TNRC18 BRD4 TTLL4 NUFIP2 NAV1 MICAL3 LSM14A PRDM16 PRRC2B AHNAK2 SMG6	2.98e-04	1470	153	24	int:TOP3B
Interaction	RXRA interactions	ESR1 POLR2A PPARD PPARG BRD4 HSPA9 NR1H4	3.13e-04	169	153	7	int:RXRA
Interaction	SIRT1 interactions	FOXO3 ESR1 CHAF1A PPARG FASN BRD4 PES1 TAF2 HSPA9 NR1H4 PRRC2B	3.18e-04	412	153	11	int:SIRT1
Interaction	SMARCA2 interactions	DCPS PPFIA2 ESR1 CHAF1A POLR2A APC2 RELB TACC2 PPARG BRD4	3.20e-04	346	153	10	int:SMARCA2
Interaction	EGLN3 interactions	FOXO3 ERCC3 IFFO1 POLR2A PSMC4 GIGYF1 KIAA1671 DNAJA3 ZCCHC14 FAM171A1 CCNT1 FASN GTF3C1 ZNF644 BRD4 TTLL4 RAB11FIP5 PLEKHA5 PRR14L SNTB2 NOTCH3 PRRC2B	3.21e-04	1296	153	22	int:EGLN3
Interaction	TNIP2 interactions	ASXL1 RBM15 POLR2A PARP2 PSMC4 RELB PABPC5 PPARG PAPSS1 NCKAP5L MEAK7 ZNF512B KIAA1671 ZCCHC14 FAM171A1 FASN MLF1 PLEKHA5	3.33e-04	952	153	18	int:TNIP2
Interaction	FGFR1 interactions	ROCK2 PFKFB3 YES1 DNAJA3 FAM171A1 SH3PXD2B NUFIP2 RAB11FIP5 PLEKHA5 MICAL3 EPCAM ALK USP6NL SNTB2	3.36e-04	632	153	14	int:FGFR1
Interaction	UBP1 interactions	ESR1 GLYCTK ZNF512B FASN BRD4	3.39e-04	79	153	5	int:UBP1
GeneFamily	Nuclear hormone receptors	ESR1 NR6A1 PPARD PPARG NR1H4	5.43e-06	49	94	5	71
GeneFamily	Ankyrin repeat domain containing	ANKRD31 ANKRD35 ANKRD30B ANKMY1 MIB2 DGKI NOTCH3	2.69e-04	242	94	7	403
Coexpression	GSE11386_NAIVE_VS_MEMORY_BCELL_DN	SYNE1 MTSS1 RSF1 ACTN1 ARMCX2 AGL EIF4G3 EPCAM SMG6	4.44e-07	158	155	9	M372
Coexpression	LI_INDUCED_T_TO_NATURAL_KILLER_DN	INAFM2 STRBP MIB2 ACTN1 OLFML3 BGN NAV1 NOTCH3	1.64e-06	137	155	8	M2088
Coexpression	LI_INDUCED_T_TO_NATURAL_KILLER_DN	INAFM2 STRBP MIB2 ACTN1 OLFML3 BGN NAV1 NOTCH3	1.73e-06	138	155	8	MM882
Coexpression	GSE37301_MULTIPOTENT_PROGENITOR_VS_COMMON_LYMPHOID_PROGENITOR_DN	DCPS SPTLC2 ACOT9 TUT7 SELENOH ACTN1 WBP4 PES1 EPCAM	3.15e-06	200	155	9	M8842
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	KIF21B ASXL1 NBEAL1 SETD2 FASN GTF3C1 TTLL4 PRR14L	1.23e-05	180	155	8	M8239
Coexpression	GSE14308_TH1_VS_TH17_DN	ACOT9 PABPC5 MEAK7 ZNF512B SETD2 AGL WBP4 RCL1	2.64e-05	200	155	8	M3374
Coexpression	GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_DN	RBM15 RELB PFKFB3 CCNT1 TAX1BP1 NAV1 RAB11FIP5 SNTB2	2.64e-05	200	155	8	M9653
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	TRPM7 TACC2 XIRP2 PLEKHA5 MICAL3 PRDM16 RPL3L ALPK2	3.39e-07	189	155	8	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	RV\|World / Chamber and Cluster_Paper	TRPM7 MTSS1 XIRP2 NAV1 MICAL3 PRDM16 RPL3L	3.42e-06	181	155	7	bbe1e6e59d8889bd37d6e8303116cbdcafca7236
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROCK2 ESR1 POLR2A RELB CCNT1 SETD2 SNTB2	3.95e-06	185	155	7	eb7d3c1363d5fedc611f9c1a91ea823de251355e
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL26A1 PPFIA2 BGN MYO3A DGKI NR1H4 NOTCH3	4.24e-06	187	155	7	fa01a61bfd13feb033ba1e35cf513707b1bff8c8
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	TRPM7 TACC2 XIRP2 MICAL3 PRDM16 RPL3L ALPK2	4.24e-06	187	155	7	78cdcf8bc141d3b155c3c8af908431fc419c4d08
ToppCell	TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma\|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9	HIVEP2 MTSS1 SH3PXD2B GTF3C1	4.52e-06	32	155	4	ba89b22a5ce8ee9f3099b1fa84721724b94c7759
ToppCell	TCGA-Bone_and_Soft_Tissue-Primary_Tumor\|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9	HIVEP2 MTSS1 SH3PXD2B GTF3C1	4.52e-06	32	155	4	58b212d4f2955f06a195df0f79ad95a8ff145b83
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|RV / Chamber and Cluster_Paper	TRPM7 TACC2 MLF1 MICAL3 PRDM16 RPL3L ALPK2	4.55e-06	189	155	7	9c1debd65c13d63fd4f3158917d621b44b714c26
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	OXR1 SYNE1 VAT1L PFKFB3 PTK2 FAM171A1 PRDM16	4.55e-06	189	155	7	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	renal_medulla_nuclei-Adult_normal_reference\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	FOXO3 MTSS1 VAT1L PFKFB3 PTK2 EIF4G3 PRDM16	4.71e-06	190	155	7	f1363f7806cfc4f14fbc1b0e8dac2de813a88eee
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	TRPM7 TACC2 PLEKHA5 MICAL3 PRDM16 RPL3L ALPK2	4.71e-06	190	155	7	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	SLC25A27 ASXL1 HIVEP2 RELB PPARD NUFIP2 MLF1	5.04e-06	192	155	7	6bba80887d6f64cf913a5c22f62baaddda417ce0
ToppCell	wk_20-22-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	COL26A1 VAT1L ACTN1 PTK2 BGN MYOZ1 NOTCH3	5.22e-06	193	155	7	ba6eb29478d16589172f48f9992e5116328c81d6
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	COL26A1 VAT1L ACTN1 PTK2 BGN MYOZ1 NOTCH3	5.77e-06	196	155	7	40cae477b3906623d1f2a4c630279e710499ce80
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HIVEP2 OXR1 STRBP SYNE1 PPFIA2 DGKI PLEKHA5	6.17e-06	198	155	7	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ROCK2 HIVEP2 OXR1 STRBP SYNE1 DGKI PLEKHA5	6.17e-06	198	155	7	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	normal_Lung-Fibroblasts-Smooth_muscle_cells\|Fibroblasts / Location, Cell class and cell subclass	ACTN1 PTK2 BGN KIAA1671 MYO3A MYOZ1 NOTCH3	6.37e-06	199	155	7	d65847ceb68a560798df3f73e6f838e7c3e38a1c
ToppCell	LPS_only-Mesenchymal_myocytic-Pericyte\|LPS_only / Treatment groups by lineage, cell group, cell type	NBEAL1 SYNE1 ACTN1 PTK2 BGN POSTN NOTCH3	6.59e-06	200	155	7	8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f
ToppCell	Sepsis-Bac-SEP-Lymphocyte-T/NK-NK_CD56bright\|Bac-SEP / Disease, condition lineage and cell class	SCLY MIB2 GTPBP1 ZNF365 PTK2 RCL1 MLF1	6.59e-06	200	155	7	ebab762fe5209c23c5a9ac9281f728fafa433af3
ToppCell	LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_only / Treatment groups by lineage, cell group, cell type	SYNE1 TACC2 ACTN1 PTK2 BGN MYOZ1 NOTCH3	6.59e-06	200	155	7	7c62678cf408aaaf98d6df0fb27814d2007c4521
ToppCell	E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ASXL1 ESR1 RELB OLFML3 FAM171A1 ALPK2	1.67e-05	154	155	6	e65e4636646164610f33f7bbac0d879a3ea55986
ToppCell	droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF21B DPH7 POLR2A PFKFB3 MINDY4 USP6NL	1.93e-05	158	155	6	1d78578dc1f8ba43dacdccae1082c0b9d749f64d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ROCK2 SYNE1 MTSS1 PPARG POSTN NOTCH3	2.01e-05	159	155	6	5ca96db4281abb5f646150ccf36adc66ab201c78
ToppCell	CV-Healthy-3\|CV / Virus stimulation, Condition and Cluster	ANKRD31 INAFM2 TRPM7 CDHR1 TTLL4 NAV1	2.15e-05	161	155	6	fd4a79385ea967b9900dc76a3add813b894a3a28
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic-CD1c-positive_myeloid_dendritic_cell\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	FOXO3 ACOT9 MTSS1 PFKFB3 NAV1 ALPK2	2.92e-05	170	155	6	cc66ac6846c58be9493eb270644ee3ce0f86cfea
ToppCell	facs-Large_Intestine-Distal-18m-Epithelial-epithelial_cell_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIVEP2 CHAF1A CNTLN NCCRP1 SH3PXD2B UTP20	3.22e-05	173	155	6	a5172dee859bf6c2eed46c48bd64dfef0ff9f28f
ToppCell	facs-Large_Intestine-Distal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIVEP2 CHAF1A CNTLN NCCRP1 SH3PXD2B UTP20	3.22e-05	173	155	6	639b5b0b33ce5aa0bc26363c059717012ddc14c0
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SYNE1 MTSS1 VAT1L BGN POSTN NOTCH3	3.55e-05	176	155	6	e9152defb4fd41267fb33c42c01fd0c683280783
ToppCell	390C-Fibroblasts-Fibroblast-B_(Myofibroblast)\|390C / Donor, Lineage, Cell class and subclass (all cells)	PABPC5 CCDC168 OLFML3 BGN POSTN GALNT5	3.55e-05	176	155	6	852d3da0907fe87c0ef23d75a63ce07619cf0c54
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SYNE1 MTSS1 VAT1L BGN POSTN NOTCH3	3.55e-05	176	155	6	a4d269075aa0efc46fa251b379f334e50c69391d
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SYNE1 MTSS1 VAT1L BGN POSTN NOTCH3	3.55e-05	176	155	6	cc6f65a7d2c622841c9d1ab3755586039d4ccc4d
ToppCell	390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	PABPC5 CCDC168 OLFML3 BGN POSTN GALNT5	3.55e-05	176	155	6	d2df1e435996c51213e88270af9f928e9e09a6f5
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL26A1 OXR1 SPTLC2 SYNE1 MTSS1 PFKFB3	3.66e-05	177	155	6	da8802a6351d3e510822f82e2fde8a4314a2216e
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC3-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NBEAL1 ACOT9 RELB NCCRP1 KIAA1671 ALPK2	3.66e-05	177	155	6	d34b086a5931d7f1737a504952d51c47693e91a8
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6\|TCGA-Ovary / Sample_Type by Project: Shred V9	IFFO1 SYNE1 BGN SH3PXD2B GALNT5 ALPK2	3.78e-05	178	155	6	142879e9393e721f9b05a6bb46995c9d6d713c95
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7\|TCGA-Colorectal / Sample_Type by Project: Shred V9	FOXO3 ASXL1 HIVEP2 BGN WBP4 LSM14A	3.78e-05	178	155	6	edc76b8f15056ec1c9a1c61a048b6331a92592d6
ToppCell	COVID-19-kidney-Epi_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL26A1 OXR1 MYO3A MICAL3 NR1H4 ALPK2	3.78e-05	178	155	6	544379f5a6145429762258d426b876bb36c112f5
ToppCell	droplet-Heart-4Chambers-21m-Mesenchymal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF21B ERCC3 PPFIA2 ARMCX2 IDNK NOTCH3	3.90e-05	179	155	6	b44e2d53b82c3c141bfc6539054b19708200a0d9
ToppCell	390C-Lymphocytic-ILC-ILC-1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ZFAT HIVEP2 DONSON RELB TTC21B PLEKHA5	3.90e-05	179	155	6	3edcd1356e49b1f5514c585861999e079ca5e579
ToppCell	human_hepatoblastoma-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	HIVEP2 OXR1 ESR1 PPARD XIRP2 ALK	3.90e-05	179	155	6	14fc8ccb6b215063d747643f47d780d2b237eb67
ToppCell	droplet-Limb_Muscle-nan-3m-Mesenchymal-skeletal_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRRC30 MYOZ1 XIRP2 MLF1 RPL3L ALPK2	4.28e-05	182	155	6	edfc598b7199ca1d8a399b264ab863c299b1eede
ToppCell	droplet-Limb_Muscle-nan-21m-Mesenchymal-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRRC30 MYOZ1 XIRP2 MLF1 RPL3L NOTCH3	4.41e-05	183	155	6	6f5dbac2748f50105f0f548d189c42ef14287019
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IKZF2 TACC2 NR6A1 MYO3A GALNT5 PRDM16	4.83e-05	186	155	6	4e94158db52df41d71e67b02b9895a358eebee0f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	OXR1 NR6A1 PLEKHA5 MICAL3 NR1H4 ALPK2	4.83e-05	186	155	6	b87acc80b7baa41681e4ed11d5537b9fbf5832f5
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	TRPM7 TACC2 XIRP2 MICAL3 PRDM16 RPL3L	5.12e-05	188	155	6	0758b474457efa36488e0195f7357100f4b6a090
ToppCell	15-Distal-Mesenchymal-Pericyte\|Distal / Age, Tissue, Lineage and Cell class	PPFIA2 PTK2 BGN MYO3A MYOZ1 NOTCH3	5.12e-05	188	155	6	4963382e54aac06bf5047c7d725393db70667ee7
ToppCell	facs-MAT-Fat-18m\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RBM15 HIVEP2 RBM42 PSMC4 GIGYF1 PSME2	5.12e-05	188	155	6	7f0cda7aab442aa9511d4c35569ec2389e014a71
ToppCell	RA-10._Endothelium_II\|World / Chamber and Cluster_Paper	OXR1 ACTN1 PKHD1L1 KIAA1671 POSTN DGKI	5.28e-05	189	155	6	75c248b9de5e2fb7a0baa8cdbab516e575cc4394
ToppCell	RA-10._Endothelium_II\|RA / Chamber and Cluster_Paper	OXR1 PKHD1L1 KIAA1671 POSTN DGKI SNTB2	5.28e-05	189	155	6	c81787a8c662db5d7814c583dd64562857629e81
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL26A1 OXR1 SYNE1 MTSS1 PFKFB3 EPCAM	5.43e-05	190	155	6	b855b8b7d3439023390ca44629c1a99f5d4c6801
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NR6A1 KIAA1671 PLEKHA5 MICAL3 NR1H4 ALPK2	5.59e-05	191	155	6	3c464645d0e7e423f791bd63bf5bcf11f6b590d3
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NR6A1 KIAA1671 PLEKHA5 MICAL3 NR1H4 ALPK2	5.59e-05	191	155	6	1c1d13144259b998d4a0e85142f7afef2ef1e63f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FOXO3 NBEAL1 PPFIA2 ACTN1 BGN NOTCH3	5.59e-05	191	155	6	04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRRC30 MYOZ1 XIRP2 MLF1 RPL3L NOTCH3	5.59e-05	191	155	6	f932980baa032748857cb367a55c37dd975c693e
ToppCell	P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ARMCX2 OLFML3 PTK2 POSTN RCL1 NOTCH3	5.59e-05	191	155	6	2ad717b59215ad8d933e9637d363b65d7298e5d4
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PPFIA2 VAT1L BGN MYO3A DCLK3 NOTCH3	5.76e-05	192	155	6	55f95454399fd533df75db06584eaa48d6ee3830
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANKRD35 OLFML3 BGN POSTN SH3PXD2B GALNT5	5.76e-05	192	155	6	f88aba74d6e8c594c32fe2bc095b5da28b4b28e9
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANKRD35 OLFML3 BGN POSTN SH3PXD2B GALNT5	5.76e-05	192	155	6	41a8326cd5bc19ad5041068501bab4c72399222e
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	TACC2 VAT1L ACTN1 BGN MYO3A NOTCH3	5.93e-05	193	155	6	000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ASXL1 HIVEP2 RELB PPARD NUFIP2 MLF1	5.93e-05	193	155	6	dbf0fe496254320c894568c31e5f9ce63707d1b5
ToppCell	droplet-Limb_Muscle-MUSCLE\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROCK2 COL26A1 TUT7 PFKFB3 POSTN TAX1BP1	6.10e-05	194	155	6	e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCell	LV-10._Endothelium_II\|LV / Chamber and Cluster_Paper	ACTN1 PKHD1L1 KIAA1671 POSTN DGKI SNTB2	6.10e-05	194	155	6	b6cc849fa08599bff9839ef382d190cc964e273e
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PTK2 BGN MYO3A MYOZ1 DCLK3 NOTCH3	6.27e-05	195	155	6	815ac5dacd382b11abb32011ed1c0635b0ddc779
ToppCell	Children_(3_yrs)-Immune-monocyte-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SPTLC2 MTSS1 PFKFB3 SH3PXD2B MYO1F NAV1	6.27e-05	195	155	6	81a28289eda1a8a1a31b7357106f64ac5000e172
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROCK2 OLFML3 MYOZ1 PLEKHA5 RPL3L SNTB2	6.27e-05	195	155	6	5c86fddd6d0530beecf45ea5ba6b823123847696
ToppCell	normal-na-Lymphocytic_NK\|normal / PBMC cell types (v2) per disease, treatment status, and sex	SYNE1 MIB2 YES1 SIGLEC7 GTF3C1 MYO1F	6.27e-05	195	155	6	cebe79c42af5910353ba9ad7d0edb01982f772a3
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PTK2 BGN MYO3A DCLK3 NR1H4 NOTCH3	6.45e-05	196	155	6	c16fbd23d9e117831b55ab3da5b08b22dd972432
ToppCell	normal-na-Lymphocytic_NK-NK_dim-female\|normal / PBMC cell types (v2) per disease, treatment status, and sex	SYNE1 MIB2 YES1 SIGLEC7 GTF3C1 MYO1F	6.45e-05	196	155	6	61bc0d161e01f36e5bcda4d4f4693afbfe5654bb
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_NK-NK_CD16\|lymph-node_spleen / Manually curated celltypes from each tissue	SYNE1 MTSS1 YES1 SIGLEC7 GTF3C1 MYO1F	6.45e-05	196	155	6	f7e5a7fad4547e8ab9ab8b140239281832fb4260
ToppCell	normal-na-Lymphocytic_NK-NK_dim\|normal / PBMC cell types (v2) per disease, treatment status, and sex	SYNE1 MIB2 YES1 SIGLEC7 GTF3C1 MYO1F	6.45e-05	196	155	6	3360d96dc06241498995bcb875615bd4c1424f5a
ToppCell	wk_20-22-Mesenchymal-Myofibro_&_SMC-Pericyte\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	COL26A1 PTK2 BGN MYO3A DCLK3 NOTCH3	6.64e-05	197	155	6	44cd1ece3633a31e8c9b667cd3cbc2749c06f478
ToppCell	RV-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	NAGK TACC2 MICAL3 PRDM16 ALPK2	6.82e-05	122	155	5	1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PTK2 BGN MYO3A MYOZ1 DCLK3 NOTCH3	7.02e-05	199	155	6	f1723cfd6fbb8c8903a3b167872ec8523e3be250
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SYNE1 GDF6 MTSS1 TACC2 VAT1L NAV1	7.02e-05	199	155	6	19a97e27a4758e794ce7246d295e112b47931a48
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	NBEAL1 ACTN1 BGN POSTN NR1H4 NOTCH3	7.22e-05	200	155	6	cf883ba5dbe6350b93142d625a52b25ff2a8bb63
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Pericyte\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SYNE1 ACTN1 BGN POSTN NR1H4 NOTCH3	7.22e-05	200	155	6	b22cae282591d8dead9869c2adbb9632615f50f7
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Interneuron\|10w / Sample Type, Dataset, Time_group, and Cell type.	KIF21B PPFIA2 MTSS1 PFKFB3 NAV1 EPCAM	7.22e-05	200	155	6	f5c63ef52bd7a898cf009b8bf9b2f7f4890d1c9b
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_only / Treatment groups by lineage, cell group, cell type	SYNE1 TACC2 CNTLN BGN POSTN DCLK3	7.22e-05	200	155	6	593bf6a7c557437db9a9249a5058a46014179ef6
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SYNE1 TACC2 ACTN1 CNTLN BGN POSTN	7.22e-05	200	155	6	08bf8c00eee6468215edb3611296bfc8784c4d56
ToppCell	COVID-19_Mild-NK\|COVID-19_Mild / Disease condition and Cell class	SYNE1 MTSS1 YES1 SIGLEC7 GTF3C1 MYO1F	7.22e-05	200	155	6	b586b0f1127293c2f8529be16b24229359041da2
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SYNE1 TACC2 ACTN1 BGN POSTN DCLK3	7.22e-05	200	155	6	dcdaec3ca3a3024dc1b8788c417003f84c2bffdc
ToppCell	LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_only / Treatment groups by lineage, cell group, cell type	NBEAL1 PPFIA2 ACTN1 BGN POSTN NOTCH3	7.22e-05	200	155	6	69edc375d85689300d1dbc1217fedc40063ecdcb
ToppCell	mLN-Dendritic_cell-Lymphoid_DC\|Dendritic_cell / Region, Cell class and subclass	CNTLN NCCRP1 SETD2 WBP4 RCL1 NAV1	7.22e-05	200	155	6	3813fa1ee1462ba83fd8b6253070f46f0b063084
ToppCell	LPS_only-Mesenchymal_myocytic\|LPS_only / Treatment groups by lineage, cell group, cell type	SYNE1 TACC2 ACTN1 BGN POSTN NOTCH3	7.22e-05	200	155	6	8bc9923f82bfb836e2f524204c92050edeae8ca5
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_B1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ZFAT INAFM2 MYOZ1 PRDM16 AHNAK2	7.94e-05	126	155	5	10e1448a03f79965b72922fd83ef51de1b7b474f
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NCCRP1 DGKI INCA1 MIEF2 AHNAK2	1.59e-04	146	155	5	ec1f793409d1a81c0f9323eb3c82ffe01dae0e44
ToppCell	PND28-Immune-Immune_Myeloid-DC-maDC\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZFAT RELB PSME2 PFKFB3 UTF1	1.97e-04	153	155	5	b03375c54aa701817c0fc2c3fef32b870169e697
ToppCell	PND28-Immune-Immune_Myeloid-DC-maDC-maDC_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZFAT RELB PSME2 PFKFB3 UTF1	1.97e-04	153	155	5	18bd770a18e642581a6df144d47184c1ac383713
ToppCell	facs-Skin-Telogen-3m-Epithelial-inner_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX1 PCDHB2 ACTN1 POSTN EPCAM	2.16e-04	156	155	5	ba9dfee9373d657d2a55572b41fc62001ad8b037
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PPFIA2 BGN POSTN ALK NOTCH3	2.23e-04	157	155	5	bfec34182f052cf1c0d847ba53ea335d4d1190de
ToppCell	facs-Heart-RV-24m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MLF1 DGKI MYO15A RPL3L NOTCH3	2.29e-04	158	155	5	2ef43d14ee65d004dc62c12ff209bbe12e4db681
ToppCell	Leuk-UTI-Lymphocyte-T_NK-gdT\|Leuk-UTI / Disease, Lineage and Cell Type	IKZF2 SYNE1 KIAA1671 GTF3C1 PRDM16	2.29e-04	158	155	5	c4b0af25608cee3d0d2b0193f5ff45d9dc87078b
ToppCell	5'-Adult-Appendix-Epithelial-Tuft-related\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SPTLC2 MTSS1 NCCRP1 FAM171A1 DGKI	2.57e-04	162	155	5	ded08da888d8c481f0f96d1e0bfd03d617966910
ToppCell	COVID-19-kidney-PEC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	OXR1 MYO3A MICAL3 NR1H4 ALPK2	3.04e-04	168	155	5	a086c306be430adf0632ba53e98cd8014d2de330
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL26A1 OLFML3 BGN POSTN AHNAK2	3.13e-04	169	155	5	031465190cd3623a25ef2b868daab8d932c8ff08
ToppCell	ILEUM-non-inflamed-(3)_mature_DC\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	NR6A1 CNTLN NCCRP1 MYOZ1 NAV1	3.21e-04	170	155	5	60151394460e6f27a42fab434e8b7b2adc78b128
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-mLTo\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VAT1L ACTN1 BGN MLF1 ALPK2	3.21e-04	170	155	5	7653f1205d4e62abe7e31b1d76f9bbd665e45667
ToppCell	facs\|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RBM15 INAFM2 POLR2A ZNF512B PRR14L	3.30e-04	171	155	5	c9990bc041a632b2f7bbebbfe737772c423d7027
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SYNE1 PPARG POSTN DCLK3 NOTCH3	3.39e-04	172	155	5	08a3fe536b1b064c5ee7779bc2b1115a5963a26b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SYNE1 PPARG POSTN DCLK3 NOTCH3	3.39e-04	172	155	5	553701349444eb366df3c11f54bb093434f153c6
Drug	cilnidipine	ESR1 PPARD PPARG NR1H4	7.12e-08	7	155	4	ctd:C065927
Drug	lacidipine	ESR1 PPARD PPARG NR1H4	7.12e-08	7	155	4	ctd:C060285
Drug	1,4-dihydropyridine	ESR1 PPARD PPARG NR1H4	4.20e-07	10	155	4	ctd:C038806
Drug	Idarubicin	ESR1 PPARD PPARG NR1H4	2.66e-06	15	155	4	ctd:D015255
Disease	Malignant neoplasm of breast	ERCC3 STRBP SYNE1 ESR1 APC2 BAG1 TACC2 ZNF365 BGN ZCCHC14 SETD2 FASN ZNF644 TAX1BP1 WBP4 UTP20 GALNT5 ALK NOTCH3 SLC17A6	5.75e-07	1074	150	20	C0006142
Disease	Migraine Disorders	ESR1 PRDM16 NOTCH3	3.55e-05	13	150	3	C0149931
Disease	Intellectual Disability	HIVEP2 OXR1 ACOT9 SYNE1 APC2 TMX2 SETD2 FASN BRD4 TAF2	1.02e-04	447	150	10	C3714756
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	DNHD1 MYO3A SETD2 DCLK3 ALK HSPA9	1.14e-04	148	150	6	C0279702
Disease	Sotos' syndrome	APC2 SETD2	1.53e-04	4	150	2	C0175695
Disease	Metastatic melanoma	ROCK2 SCYL1 PTK2 ALPK2	1.67e-04	54	150	4	C0278883
Disease	Ovarian Serous Adenocarcinoma	TRPM7 MYO3A ALK	2.12e-04	23	150	3	C1335177
Disease	Macrothrombocytopenia	TRPM7 ACTN1	2.54e-04	5	150	2	C2751260
Disease	colorectal cancer (implicated_via_orthology)	APC2 YES1 NOTCH3	4.73e-04	30	150	3	DOID:9256 (implicated_via_orthology)
Disease	Polycystic kidney disease, type 2	PPARG BRD4	5.30e-04	7	150	2	C2751306
Disease	reaction time measurement	FOXO3 ZFAT NAGK DNAJC27 TACC2 FAM171A1 SETD2 BRD4 NUFIP2 DGKI EIF4G3	5.67e-04	658	150	11	EFO_0008393
Disease	cortical thickness	FOXO3 COL26A1 NBEAL1 STRBP CHAF1A GDF6 TACC2 SH3PXD2B NAV1 DGKI MICAL3 LSM14A EIF4G3 MIEF2 SMG6	5.71e-04	1113	150	15	EFO_0004840
Disease	Obesity	FOXO3 ESR1 PFKFB3 PPARD PPARG FASN	6.52e-04	205	150	6	C0028754
Disease	neuroticism measurement, cognitive function measurement	FOXO3 ASXL1 NBEAL1 DNAJC27 ZCCHC14 GTF3C1 NAV1 RAB11FIP5 DGKI EIF4G3	6.63e-04	566	150	10	EFO_0007660, EFO_0008354
Disease	cervix carcinoma (is_marker_for)	BAG1 PTK2	7.04e-04	8	150	2	DOID:2893 (is_marker_for)
Disease	Polycystic Kidney, Type 1 Autosomal Dominant Disease	PPARG BRD4	7.04e-04	8	150	2	C0887850
Disease	lean body mass	FOXO3 ZFAT HIVEP2 TRPM7 PPFIA2 ESR1 APC2 DGKI	7.44e-04	379	150	8	EFO_0004995
Disease	Nonsyndromic Deafness	MYO3A MYO1F STRC MYO15A	7.88e-04	81	150	4	C3711374
Disease	colon cancer (is_implicated_in)	CHAF1A PPARG BRD4	8.13e-04	36	150	3	DOID:219 (is_implicated_in)
Disease	Acute Confusional Migraine	ESR1 PRDM16	9.03e-04	9	150	2	C0521664
Disease	Status Migrainosus	ESR1 PRDM16	9.03e-04	9	150	2	C0338489
Disease	Polycystic Kidney, Autosomal Dominant	PPARG BRD4	9.03e-04	9	150	2	C0085413
Disease	Abdominal Migraine	ESR1 PRDM16	9.03e-04	9	150	2	C0270858
Disease	idiopathic pulmonary fibrosis (is_implicated_in)	SETD2 BRD4	9.03e-04	9	150	2	DOID:0050156 (is_implicated_in)
Disease	Sick Headaches	ESR1 PRDM16	9.03e-04	9	150	2	C0700438
Disease	Cervical Migraine Syndrome	ESR1 PRDM16	9.03e-04	9	150	2	C0007852
Disease	Hemicrania migraine	ESR1 PRDM16	9.03e-04	9	150	2	C0018984
Disease	Giant Cell Glioblastoma	PPARG PTK2 BRD4 NOTCH3	9.03e-04	84	150	4	C0334588
Disease	Neoplasm Recurrence, Local	ASXL1 ESR1 ALK	1.03e-03	39	150	3	C0027643
Disease	body height at birth	HIVEP2 STRBP ESR1	1.11e-03	40	150	3	EFO_0006784
Disease	Mammary Carcinoma, Human	SYNE1 ESR1 APC2 BAG1 ZNF365 SETD2 FASN ALK NOTCH3	1.51e-03	525	150	9	C4704874
Disease	Mammary Neoplasms, Human	SYNE1 ESR1 APC2 BAG1 ZNF365 SETD2 FASN ALK NOTCH3	1.51e-03	525	150	9	C1257931
Disease	Mammary Neoplasms	SYNE1 ESR1 APC2 BAG1 ZNF365 SETD2 FASN ALK NOTCH3	1.55e-03	527	150	9	C1458155
Disease	eosinophil percentage of leukocytes	ZFAT IKZF2 HIVEP2 NAGK DCPS PPARG TULP1 SETD2 RCL1 EIF4G3 ALPK2	1.56e-03	746	150	11	EFO_0007991
Disease	selective IgA deficiency disease	PFKFB3 FAM171A1 FASN	1.67e-03	46	150	3	EFO_1001929
Disease	melanoma	ERCC3 PPARD PPARG FASN ALK USP6NL	1.73e-03	248	150	6	C0025202
Disease	Breast Carcinoma	SYNE1 ESR1 APC2 BAG1 ZNF365 SETD2 FASN ALK NOTCH3	1.79e-03	538	150	9	C0678222
Disease	Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive	MYO3A STRC MYO15A	2.24e-03	51	150	3	cv:CN043650
Disease	Left ventricular noncompaction	MIB2 PRDM16	2.24e-03	14	150	2	C1960469
Disease	Antihypertensive use measurement	HIVEP2 UBE3B YES1 OLFML3 PRDM16 SMG6	2.42e-03	265	150	6	EFO_0009927
Disease	non-alcoholic fatty liver disease	PPARG FAM171A1 MICAL3 ALPK2 SMG6	2.43e-03	182	150	5	EFO_0003095
Disease	serum gamma-glutamyl transferase measurement	FOXO3 IKZF2 TRPM7 PPARG YES1 SETD2 SH3PXD2B WBP4 MICAL3 USP6NL NR1H4 ALPK2	2.53e-03	914	150	12	EFO_0004532
Disease	Colorectal Neoplasms	DONSON TRPM7 SYNE1 APC2 PPARG POSTN	3.01e-03	277	150	6	C0009404
Disease	neuroimaging measurement	FOXO3 KIF21B COL26A1 NBEAL1 CHAF1A TACC2 MEAK7 PTK2 DNAJA3 DGKI PRDM16 SNTB2 SMG6	3.26e-03	1069	150	13	EFO_0004346
Disease	Atherosclerosis	ESR1 PPARG NR1H4	3.40e-03	59	150	3	C0004153
Disease	Atherogenesis	ESR1 PPARG NR1H4	3.40e-03	59	150	3	C1563937
Disease	bone density	ESR1 TACC2 TTC21B RAB11FIP5 MINDY4 MYO15A SMG6	3.80e-03	388	150	7	EFO_0003923
Disease	FEV/FEC ratio	FOXO3 ASXL1 HIVEP2 STRBP TUT7 PPARG MEAK7 PTK2 MYO1F NAV1 MICAL3 MYO15A PRDM16 SMG6	4.06e-03	1228	150	14	EFO_0004713
Disease	Adenocarcinoma of lung (disorder)	FOXO3 STRBP FASN RCL1 ALK	4.13e-03	206	150	5	C0152013
Disease	dense area measurement, mammographic density measurement	ESR1 ZNF365	4.15e-03	19	150	2	EFO_0005941, EFO_0006503
Disease	Pseudopelade	PPARG BRD4	4.15e-03	19	150	2	C0086873
Disease	Sarcomatoid Renal Cell Carcinoma	DNHD1 SETD2 ALK HSPA9	4.20e-03	128	150	4	C1266043
Disease	Chromophobe Renal Cell Carcinoma	DNHD1 SETD2 ALK HSPA9	4.20e-03	128	150	4	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	DNHD1 SETD2 ALK HSPA9	4.20e-03	128	150	4	C1266044
Disease	Papillary Renal Cell Carcinoma	DNHD1 SETD2 ALK HSPA9	4.20e-03	128	150	4	C1306837
Disease	Renal Cell Carcinoma	DNHD1 SETD2 ALK HSPA9	4.20e-03	128	150	4	C0007134
Disease	Global developmental delay	OXR1 POLR2A APC2 TMX2	4.81e-03	133	150	4	C0557874
Disease	Microcephaly	DONSON TMX2 BRD4	4.86e-03	67	150	3	C0025958
Disease	Infiltrating duct carcinoma of female breast	TRPM7 DCLK3	5.06e-03	21	150	2	C3165106

Protein segments in the cluster

Peptide	Gene	Start	Entry
MAEKRNSRAKLEPGF	TTC21B	1011	Q7Z4L5
AGSRENMKELKEARP	SMG6	26	Q86US8
AEMNGSKLGRRAKPE	EPCAM	71	P16422
LKVVAMDGDRGKPNR	CDHR1	266	Q96JP9
VISGERLAKPERGKM	ACTN1	71	P12814
MKRLLAAAGKGVRGP	ANKRD30B	1	Q9BXX2
GSGMTEIRKIKRADP	CNTLN	586	Q9NXG0
IMIVQAKGRGRGRKE	BRD4	171	O60885
SRKSARVRQPGMKGN	ALPK2	531	Q86TB3
HRKRMPVKEVRGGQT	GTPBP1	446	O00178
LAKSQDGLPPRRMKD	ACOT9	71	Q9Y305
RGAAAGARRPRMKKK	BAG1	61	Q99933
KDAARGALSRPVMEG	ANKRD35	506	Q8N283
DKTALKMRIPVAGGD	CCNT1	456	O60563
LTEGRGKGLMRNQKR	DNHD1	3581	Q96M86
DGVPERRKFGRMKLL	CHAF1A	546	Q13111
MADAAPQLGKRKREL	DCPS	1	Q96C86
KRMAKPKNRAVAGTG	ARMCX2	36	Q7L311
KPATGQMKRNRGEEI	ASXL1	236	Q8IXJ9
EMVNRAKRKAGVDPL	NAGK	51	Q9UJ70
VGKPAEMRSGQLSRK	NBEAL1	2656	Q6ZS30
QLTDPGKIKRIRGMA	RCL1	181	Q9Y2P8
GDDLRRPATMKGKER	RBM15	36	Q96T37
EMNGKYVGSRPIKLR	RBM42	441	Q9BTD8
EGARKEERKPRMGLF	RAB11FIP5	451	Q9BXF6
GVDKKRKRGMPDVLG	RELB	406	Q01201
QVRSMKILKRFGGPA	OLFML3	141	Q9NRN5
KPRMGASAGRIKGDE	NR1H4	121	Q96RI1
RCQRQESKKMPVAGG	PARP2	41	Q9UGN5
MEAGEGKERVPKQRQ	PCDHB2	1	Q9Y5E7
PGMKAGRINKRNARG	ANKRD31	1141	Q8N7Z5
MNEPKSARKGRGDAL	FAM171A1	746	Q5VUB5
SIGIRRQGSMKKEFP	MICAL3	741	Q7RTP6
LGPGEGSKAKRRALM	GIGYF1	996	O75420
GGVEQRRRSLKEMPD	KIAA1671	1241	Q9BY89
GGSPLRREVKMEARK	NCKAP5L	946	Q9HCH0
RPEALRKDGGKVFMK	MYO15A	2591	Q9UKN7
MLGVKPGASRDEVNK	DNAJC27	221	Q9NZQ0
RGKARTGGPMEVKLE	EIF4E1B	46	A6NMX2
SQPGELRGRKIMKRI	KIAA1109	3526	Q2LD37
EAEKEKKPCMSGGRR	DCLK3	296	Q9C098
FLHKAKNRMEPGGLR	NCCRP1	246	Q6ZVX7
GGRMLKHKRQRDDGE	ESR1	261	P03372
MAPKRAKRRTVEGGS	MYLPF	1	Q96A32
PQGEDMLNAIRRGVK	MTSS1	726	O43312
IRKVPKGVFSGLRNM	BGN	171	P21810
SEDAKKGPNPLMRRN	PFKFB3	446	Q16875
AKPMSERVAGRAGLK	KIF21B	826	O75037
KGRREPVGQDALGMK	NOTCH3	1691	Q9UM47
RFGIRRDGPMKFEKD	LSM14A	281	Q8ND56
SDMKLQDGKRLLGPQ	MEAK7	171	Q6P9B6
DGERLVGMPAKRQAV	HSPA9	96	P38646
ERPAVIEKLTGNMGK	IKZF2	261	Q9UKS7
FQVPSMGGRKRERKA	IFFO1	356	Q0D2I5
KAVDEMNGRIVGSKP	PABPC5	356	Q96DU9
DGRRMSFQKPKGTIE	OXR1	86	Q8N573
MRKLAREGQKPPEGF	PAPSS1	591	O43252
QPPKHRKGRQAEGEM	APC2	1731	O95996
EENRRKMGKGIPLND	IDNK	41	Q5T6J7
SVPKGIRAAMERAGK	GLYCTK	111	Q8IVS8
KGGMEVKEPQVRLGR	DPH7	51	Q9BTV6
SKRGMEQENKGRPFV	DGKI	351	O75912
ERKMQNALGRGKVVP	GALNT5	111	Q7Z7M9
GADILKPVMLRQGEK	ANKMY1	761	Q9P2S6
LFPRIGADRKMAGKT	DONSON	231	Q9NYP3
EAQRLGRVLRAKKGM	ERCC3	636	P19447
MKERAGQKQDRTGRP	CCDC168	4806	Q8NDH2
RDASGKRVMGLVPAK	FASN	1606	P49327
QTDQKIRMGGKGIPR	DNAJA3	381	Q96EY1
ADTMRLQPIGRDKDG	RSF1	146	Q96T23
LTSRGSMGREKNDKP	EIF4G3	1126	O43432
DAALRANLKMKRGGA	COL26A1	401	Q96A83
KDKGPKRMLFTGRRQ	LRRC30	11	A6NM36
GRMGVRRDEPKVKSL	PPFIA2	581	O75334
SLPGDKIRNKMVAGL	PRR14L	866	Q5THK1
MKERDAAPAERGKPA	INAFM2	1	P0DMQ5
RKKRRPCLEGMQQQG	INCA1	91	Q0VD86
DMAPALGRVGKVVKV	MIB2	356	Q96AX9
MGTQEARRCLGKPNK	MINAR1	346	Q9UPX6
NRKAIREDGMPGGRN	NR6A1	126	Q15406
QKRGKRRSDEGLGSM	MIEF2	6	Q96C03
GRKAAAADGRGMLPK	NAV1	31	Q8NEY1
AADGRGMLPKRAKAP	NAV1	36	Q8NEY1
NKAIPGKRSAVVMGR	SMG8	821	Q8ND04
GKSGKAPRRRAVSMD	FOXO3	241	O43524
RKEGKMQRAPRDSDA	GDF6	46	Q6KF10
VAPTQDLRRKGKGMV	UTP20	861	O75691
KRSLENPAERKMEGQ	TAX1BP1	591	Q86VP1
GEGPRMVRDVFRLAK	PSMC4	241	P43686
NAIRFGRMPEAEKRK	PPARD	141	Q03181
GRMPEAEKRKLVAGL	PPARD	146	Q03181
SGQKLPCEQGRRMKR	SYNE1	71	Q8NF91
AERKVAKGPMKLGAR	SCYL1	791	Q96KG9
LFKGVLKERMEGRPL	LIPI	306	Q6XZB0
RRMAQGKVASLGPIK	NDUFAF7	341	Q7L592
NKKIFRIGRGPHMED	RPL3L	281	Q92901
RIGRGPHMEDGKLVK	RPL3L	286	Q92901
VEPARMNRKKGDKGF	TAF2	6	Q6P1X5
DRKGMLQLKIAGAPE	PTK2	311	Q05397
KRKMEAGERLGPCVV	PRDM16	101	Q9HAZ2
NAIRFGRMPQAEKEK	PPARG	206	P37231
KKSARPAADVGDIGM	SIGLEC7	381	Q9Y286
GKNPVMELNEKRRGL	STRBP	511	Q96SI9
MAKPCGVRLSGEARK	PSME2	1	Q9UL46
RKGEKMGRFQVRGNP	SLC25A44	141	Q96H78
GGGAKANQDRVKRPM	SOX1	41	O00570
LGPEELRAAMGKAKQ	STRC	1501	Q7RTU9
APRMAKGDAAKLRAL	RITA1	126	Q96K30
GEGRLRIRLMPEKKA	ALK	181	Q9UM73
KGREDTEGQIRMPKF	AHNAK2	571	Q8IVF2
MGLAGRARVKEKFSP	ALG2	386	Q9H553
KNQGPSMIGRKEERL	XIRP2	2646	A4UGR9
VRNKEAPAGEGTKMR	TULP1	181	O00294
KTRKMEVGFKARGQP	TNRC18	1701	O15417
MESVKQRILAPGKEG	SLC17A6	1	Q9P2U8
GKEAMRRPQIDKKGR	TMX2	226	Q9Y320
NAARESLAKMIGGKP	SCLY	76	Q96I15
AMVRSRNPGKDDCAK	USP19	246	O94966
RPKMKALDAEDGKRG	USP6NL	531	Q92738
GRRVQLKGLIGKRAM	ZFAT	866	Q9P243
ELLGFGRKGNIRPKM	ZNF365	381	Q70YC5
LDVKRMGENSRPKSG	MINDY4	191	Q4G0A6
RGKPAVGDMLRKSSD	NUFIP2	291	Q7Z417
LAALEEQRMEGKKPR	PES1	496	O00541
PAKIGAFGREMLKRN	SPTLC2	476	O15270
PDGDAKQRSPKMRQR	SH3PXD2B	331	A1X283
QRLKGKEGRVRGNLM	POLR2A	341	P24928
KEGRVRGNLMGKRVD	POLR2A	346	P24928
MAPRGRKRKAEAAVV	SELENOH	1	Q8IZQ5
RRAPGGIKETRKAMR	MLF1	131	P58340
GVMADGVAPVFKKRR	WBP4	346	O75554
QMEGKRKLEGKPLRF	SLC25A27	156	O95847
KLAAPRAGEQGEAMK	PRRC2B	1516	Q5JSZ5
IMNRKEPVKRGNDTD	ROCK2	1041	O75116
RMPLLAKGKQATGEE	TACC2	1331	O95359
DEMPKRRLPALANKG	PKHD1L1	841	Q86WI1
GGLNKLRLFRKAMPE	VAT1L	51	Q9HCJ6
KGSELRMINKNPERE	SETD2	596	Q9BYW2
RMINKNPEREKAGSP	SETD2	601	Q9BYW2
GENRVSIRAAGGKMK	SETD2	1691	Q9BYW2
VKAMFNGGSRKRALP	SKOR2	231	Q2VWA4
RKRKAKESGMALPQG	ZNF480	11	Q8WV37
KNKRMGEERNSAISP	ZNF644	1176	Q9H582
GKDGSRKEVRLPMLH	ZNF512B	21	Q96KM6
LEERNKGSGPRSSMK	ZCCHC14	536	Q8WYQ9
KILRGKGESLRPAMN	UBE3B	176	Q7Z3V4
LMQLPGKGDSRNELK	TCHHL1	686	Q5QJ38
KLPRGVLERIMGDKV	POSTN	281	Q15063
PGALIKDIRENGMKV	RPE	101	Q96AT9
VGGKRRSMEVKPAQA	GTF3C1	1626	Q12789
DKTLGPGAEEKRRSM	PLEKHA5	481	Q9HAU0
QKAKPMRAAADLGRE	TUT7	1416	Q5VYS8
EEGKGHKRPVGMLVR	HIVEP2	1596	P31629
KGGRENRMPILISKI	SNTB2	131	Q13425
RKLTARGFEKMPRQG	TTLL4	341	Q14679
RGGFEPKMTKREAAL	DNAJC19	51	Q96DA6
KEEMGGGLRRAVKVQ	TRPM7	1616	Q96QT4
RKLMGLLGDNGRKRP	UTF1	141	Q5T230
GKMGRKDAERLLLNP	YES1	161	P07947
DKMGESDRARNRGIP	AGL	1261	P35573
RMLFPEKLDGDKKGR	MYO1F	541	O00160
LVKGFLKRGERMSEP	MYO3A	111	Q8NEV4
GLNLGKKISVPRDVM	MYOZ1	31	Q9NP98